Cipla partners with Qilu Pharmaceutical to license, supply biosimilar Keytruda
Cipla says it has partnered with Qilu Pharmaceutical for licensing and supply of a biosimilar to Keytruda for use in the US.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.